{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:35:58Z","timestamp":1791646558117,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.expneurol.2017.02.010","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T13:47:13Z","timestamp":1487252833000},"page":"134-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"291","author":[{"given":"Yuzhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kjellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"J\u00e4rnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Winstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2017.02.010_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001692","article-title":"IdeS: a bacterial proteolytic enzyme with therapeutic potential","volume":"3","author":"Johansson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-016-0291-x","article-title":"C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy","volume":"4","author":"McGonigal","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0030","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/art.22930","article-title":"Blocking of experimental arthritis by cleavage of IgG antibodies in vivo","volume":"56","author":"Nandakumar","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0035","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/01.WNL.0000129917.28461.0C","article-title":"Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration","volume":"62","author":"Nishimoto","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-510X(03)00029-7","article-title":"Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barr\u00e9 syndrome onset subsequent to Campylobacter jejuni enteritis","volume":"210","author":"Odaka","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.09.016","article-title":"Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barr\u00e9 syndrome","volume":"205","author":"Phongsisay","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0050","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0055","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.1038\/srep10809","article-title":"Streptococcal IdeS: therapeutic potential for Guillain-Barr\u00e9 syndrome","volume":"5","author":"Takahashi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0060","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/mol.113.086470","article-title":"Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase","volume":"83","author":"Tradtrantip","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/emboj\/21.7.1607","article-title":"IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G","volume":"21","author":"von Pawel-Rammingen","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2017.02.010_bb0070","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1038\/srep13931","article-title":"Action mechanism of corticosteroids to aggravate Guillain-Barr\u00e9 syndrome","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132011","article-title":"Complete removal of extracellular IgG antibodies in a randomized dose-escalation phase I study with the bacterial enzyme IdeS\u2014a novel therapeutic opportunity","volume":"10","author":"Winstedt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2017.02.010_bb0080","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T08:23:25Z","timestamp":1536049405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":16,"alternative-id":["S0014488617300444"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.02.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}